Lenz & Staehelin is advising Pfizer and Amplyx Pharmaceuticals on this transaction.Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into an asset purchase agreement with Amplyx Pharmaceuticals, an…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
